• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坎地沙坦 - PLGA微粒眼周注射可抑制激光诱导的实验性脉络膜新生血管形成。

Periocular injection of candesartan-PLGA microparticles inhibits laser-induced experimental choroidal neovascularization.

作者信息

Okuda Yoshitaka, Fukumoto Masanori, Horie Taeko, Oku Hidehiro, Takai Shinji, Nakanishi Toyofumi, Matsuzaki Kaori, Tsujimoto Hiroyuki, Ikeda Tsunehiko

机构信息

Department of Ophthalmology, Osaka Medical College, Osaka, Japan,

Department of Innovative Medicine, Graduate School of Medicine, Osaka Medical College, Osaka, Japan.

出版信息

Clin Ophthalmol. 2018 Dec 31;13:87-93. doi: 10.2147/OPTH.S181110. eCollection 2019.

DOI:10.2147/OPTH.S181110
PMID:30643382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6318708/
Abstract

PURPOSE

Microparticle technology enables local administration of medication. The purpose of this study was to examine the inhibitory effect of locally administered candesartan (CAN)-encapsulated microparticles on experimental choroidal neovascularization (CNV).

METHODS

Laser photocoagulation was used to induce CNV in Brown Norway rats. The rats were pretreated with subconjunctival injections of CAN (5.0 mg/eye) or phosphate buffer saline for 3 days before photocoagulation. The volume of CNV was evaluated 7 days after laser injury using the lectin staining technique. The infiltration of macrophages within the CNV lesion was determined using immunofluorescent staining with an anti-CD68 antibody. mRNA levels of MCP-1, IL1-β and VEGF in the retinal pigment epithelium/choroid complex were determined using quantitative PCR (q-PCR).

RESULTS

CNV volume was significantly suppressed by the treatment with CAN compared with that in vehicle-treated eyes (<0.05, two-tailed Student's -test). Subconjunctival injections of CAN decreased the numbers of CD68 cells in the CNV lesion. The increased mRNA levels of MCP-1, IL1-β, and VEGF induced by photocoagulation was significantly suppressed following the local administration of CAN (<0.05, two-tailed Student's -test).

CONCLUSION

Local administration of CAN inhibited experimentally induced CNV possibly through anti-inflammatory effects.

摘要

目的

微粒技术可实现药物的局部给药。本研究的目的是检测局部给予坎地沙坦(CAN)包裹的微粒对实验性脉络膜新生血管(CNV)的抑制作用。

方法

采用激光光凝法在挪威棕色大鼠中诱导CNV。在光凝前3天,对大鼠进行结膜下注射CAN(5.0mg/眼)或磷酸盐缓冲盐水预处理。激光损伤7天后,使用凝集素染色技术评估CNV的体积。使用抗CD68抗体的免疫荧光染色确定CNV病变内巨噬细胞的浸润情况。使用定量PCR(q-PCR)测定视网膜色素上皮/脉络膜复合体中MCP-1、IL1-β和VEGF的mRNA水平。

结果

与载体处理组相比,CAN处理显著抑制了CNV体积(<0.05,双尾Student检验)。结膜下注射CAN减少了CNV病变中CD68细胞的数量。局部给予CAN后,光凝诱导的MCP-1、IL1-β和VEGF的mRNA水平升高受到显著抑制(<0.05,双尾Student检验)。

结论

局部给予CAN可能通过抗炎作用抑制实验性诱导的CNV。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7755/6318708/5b39c18fc976/opth-13-087Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7755/6318708/a6269ac90980/opth-13-087Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7755/6318708/829e56f4546f/opth-13-087Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7755/6318708/5b39c18fc976/opth-13-087Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7755/6318708/a6269ac90980/opth-13-087Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7755/6318708/829e56f4546f/opth-13-087Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7755/6318708/5b39c18fc976/opth-13-087Fig3.jpg

相似文献

1
Periocular injection of candesartan-PLGA microparticles inhibits laser-induced experimental choroidal neovascularization.坎地沙坦 - PLGA微粒眼周注射可抑制激光诱导的实验性脉络膜新生血管形成。
Clin Ophthalmol. 2018 Dec 31;13:87-93. doi: 10.2147/OPTH.S181110. eCollection 2019.
2
Suppression of experimental choroidal neovascularization by curcumin in mice.姜黄素抑制小鼠实验性脉络膜新生血管形成。
PLoS One. 2012;7(12):e53329. doi: 10.1371/journal.pone.0053329. Epub 2012 Dec 28.
3
IKK2 inhibition using TPCA-1-loaded PLGA microparticles attenuates laser-induced choroidal neovascularization and macrophage recruitment.使用负载TPCA-1的聚乳酸-羟基乙酸共聚物(PLGA)微粒抑制IKK2可减轻激光诱导的脉络膜新生血管形成和巨噬细胞募集。
PLoS One. 2015 Mar 24;10(3):e0121185. doi: 10.1371/journal.pone.0121185. eCollection 2015.
4
Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.二十碳五烯酸在预防小鼠脉络膜新生血管形成方面具有抗炎作用。
Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4328-34. doi: 10.1167/iovs.06-1148.
5
Intravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats.玻璃体内注射伊曲康唑可抑制大鼠激光诱导的脉络膜新生血管形成。
PLoS One. 2017 Jun 30;12(6):e0180482. doi: 10.1371/journal.pone.0180482. eCollection 2017.
6
Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin.用抗炎类胡萝卜素虾青素抑制脉络膜新生血管形成。
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1679-85. doi: 10.1167/iovs.07-1426.
7
Blockade of the sonic hedgehog signalling pathway inhibits choroidal neovascularization in a laser-induced rat model.在激光诱导的大鼠模型中,抑制音猬因子信号通路可抑制脉络膜新生血管形成。
J Huazhong Univ Sci Technolog Med Sci. 2010 Oct;30(5):659-65. doi: 10.1007/s11596-010-0560-z. Epub 2010 Nov 10.
8
Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.通过抑制血管紧张素转换酶抑制脉络膜新生血管形成:缓激肽的作用极小。
Invest Ophthalmol Vis Sci. 2007 May;48(5):2321-6. doi: 10.1167/iovs.06-1296.
9
Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.抗血管内皮生长因子 A/血管内皮生长因子受体 2 或非特异性 siRNA 抑制小鼠实验性脉络膜新生血管形成。
Exp Eye Res. 2010 Sep;91(3):433-9. doi: 10.1016/j.exer.2010.06.019. Epub 2010 Jul 1.
10
Melissa officinalis extract inhibits laser-induced choroidal neovascularization in a rat model.蜜蜂花提取物抑制大鼠模型中激光诱导的脉络膜新生血管形成。
PLoS One. 2014 Oct 14;9(10):e110109. doi: 10.1371/journal.pone.0110109. eCollection 2014.

本文引用的文献

1
Different distributions of M1 and M2 macrophages in a mouse model of laser-induced choroidal neovascularization.激光诱导脉络膜新生血管小鼠模型中M1和M2巨噬细胞的不同分布
Mol Med Rep. 2017 Jun;15(6):3949-3956. doi: 10.3892/mmr.2017.6491. Epub 2017 Apr 20.
2
Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.壳聚糖包覆的贝伐单抗 PLGA 纳米粒作为新型靶向视网膜药物传递系统的研究:优化、表征和体外毒性评价。
Artif Cells Nanomed Biotechnol. 2017 Nov;45(7):1397-1407. doi: 10.1080/21691401.2016.1243545. Epub 2016 Nov 18.
3
PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization.
通过实验设计优化的聚乙二醇化聚乳酸-羟基乙酸共聚物纳米球用于右布洛芬的眼部给药——体外、离体和体内表征
Colloids Surf B Biointerfaces. 2016 Sep 1;145:241-250. doi: 10.1016/j.colsurfb.2016.04.054. Epub 2016 May 3.
4
Aflibercept for neovascular age-related macular degeneration.阿柏西普用于治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2016 Feb 8;2(2):CD011346. doi: 10.1002/14651858.CD011346.pub2.
5
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.全球与年龄相关的黄斑变性患病率及 2020 与 2040 年疾病负担预测:系统回顾和荟萃分析。
Lancet Glob Health. 2014 Feb;2(2):e106-16. doi: 10.1016/S2214-109X(13)70145-1. Epub 2014 Jan 3.
6
Tacrolimus-loaded PLGA implants: in vivo release and ocular toxicity.载他克莫司的 PLGA 植入物:体内释放和眼毒性。
Curr Eye Res. 2014 Jan;39(1):99-102. doi: 10.3109/02713683.2013.819927.
7
VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV.血管内皮生长因子受体阻断显著减少激光诱导脉络膜新生血管中的视网膜小胶质细胞/巨噬细胞浸润。
PLoS One. 2013 Aug 20;8(8):e71808. doi: 10.1371/journal.pone.0071808. eCollection 2013.
8
Mechanisms of age-related macular degeneration.年龄相关性黄斑变性的发病机制。
Neuron. 2012 Jul 12;75(1):26-39. doi: 10.1016/j.neuron.2012.06.018.
9
Macrophage polarization in the maculae of age-related macular degeneration: a pilot study.年龄相关性黄斑变性黄斑区巨噬细胞极化:一项初步研究。
Pathol Int. 2011 Sep;61(9):528-35. doi: 10.1111/j.1440-1827.2011.02695.x. Epub 2011 Aug 1.
10
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review.基于聚乳酸-共-羟基乙酸的药物释放系统的药物释放机制——综述。
Int J Pharm. 2011 Aug 30;415(1-2):34-52. doi: 10.1016/j.ijpharm.2011.05.049. Epub 2011 May 27.